Selected research
Market Outlook & Growth Opportunities
Global DNA Sequencing System Market Outlook and Growth Opportunities 2026
Market perspective
The global DNA Sequencing System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for DNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Sequencing System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the DNA Sequencing System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the DNA Sequencing System market include BGI Genomics, Biocompare, CEGAT, Eurofins Group, Gencove, Genewiz, Illumina, Macrogen and New Scale Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global DNA Sequencing System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA Sequencing System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA Sequencing System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Sequencing System market size, projected growth trends, production technologies, key applications, and end-use industries.
DNA Sequencing System Segment by Company
BGI Genomics
Biocompare
CEGAT
Eurofins Group
Gencove
Genewiz
Illumina
Macrogen
New Scale Technologies
Oxford Nanopore Technologies
Pacific Biosciences of California
Qiagen
SCIEX
Verogen
MGI Tech
Thermo Fisher Scientific
DNA Sequencing System Segment by Type
Medium Size
Small Size
Large Size
DNA Sequencing System Segment by Application
Science
Medical
Others
DNA Sequencing System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global DNA Sequencing System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions DNA Sequencing System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify DNA Sequencing System significant trends, drivers, influence factors in global and regions.
6. To analyze DNA Sequencing System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Sequencing System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Sequencing System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Sequencing System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the DNA Sequencing System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Sequencing System industry.
Chapter 3: Detailed analysis of DNA Sequencing System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of DNA Sequencing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of DNA Sequencing System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Medium Size
- Small Size
- Large Size
Applications
- Science
- Medical
- Others
Companies covered
- BGI Genomics
- Biocompare
- CEGAT
- Eurofins Group
- Gencove
- Genewiz
- Illumina
- Macrogen
- New Scale Technologies
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- Qiagen
- SCIEX
- Verogen
- MGI Tech
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global DNA Sequencing System Sales Value (2021-2032)
- 1.2.2 Global DNA Sequencing System Sales Volume (2021-2032)
- 1.2.3 Global DNA Sequencing System Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 DNA Sequencing System Market Dynamics
- 2.1 DNA Sequencing System Industry Trends
- 2.2 DNA Sequencing System Industry Drivers
- 2.3 DNA Sequencing System Industry Opportunities and Challenges
- 2.4 DNA Sequencing System Industry Restraints
3 DNA Sequencing System Market by Company
- 3.1 Global DNA Sequencing System Company Revenue Ranking in 2025
- 3.2 Global DNA Sequencing System Revenue by Company (2021-2026)
- 3.3 Global DNA Sequencing System Sales Volume by Company (2021-2026)
- 3.4 Global DNA Sequencing System Average Price by Company (2021-2026)
- 3.5 Global DNA Sequencing System Company Ranking (2024-2026)
- 3.6 Global DNA Sequencing System Company Manufacturing Base and Headquarters
- 3.7 Global DNA Sequencing System Company Product Type and Application
- 3.8 Global DNA Sequencing System Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global DNA Sequencing System Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 DNA Sequencing System Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 DNA Sequencing System Market by Type
- 4.1 DNA Sequencing System Type Introduction
- 4.1.1 Medium Size
- 4.1.2 Small Size
- 4.1.3 Large Size
- 4.2 Global DNA Sequencing System Sales Volume by Type
- 4.2.1 Global DNA Sequencing System Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global DNA Sequencing System Sales Volume by Type (2021-2032)
- 4.2.3 Global DNA Sequencing System Sales Volume Share by Type (2021-2032)
- 4.3 Global DNA Sequencing System Sales Value by Type
- 4.3.1 Global DNA Sequencing System Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global DNA Sequencing System Sales Value by Type (2021-2032)
- 4.3.3 Global DNA Sequencing System Sales Value Share by Type (2021-2032)
5 DNA Sequencing System Market by Application
- 5.1 DNA Sequencing System Application Introduction
- 5.1.1 Science
- 5.1.2 Medical
- 5.1.3 Others
- 5.2 Global DNA Sequencing System Sales Volume by Application
- 5.2.1 Global DNA Sequencing System Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global DNA Sequencing System Sales Volume by Application (2021-2032)
- 5.2.3 Global DNA Sequencing System Sales Volume Share by Application (2021-2032)
- 5.3 Global DNA Sequencing System Sales Value by Application
- 5.3.1 Global DNA Sequencing System Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global DNA Sequencing System Sales Value by Application (2021-2032)
- 5.3.3 Global DNA Sequencing System Sales Value Share by Application (2021-2032)
6 DNA Sequencing System Regional Sales and Value Analysis
- 6.1 Global DNA Sequencing System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global DNA Sequencing System Sales by Region (2021-2032)
- 6.2.1 Global DNA Sequencing System Sales by Region: 2021-2026
- 6.2.2 Global DNA Sequencing System Sales by Region (2027-2032)
- 6.3 Global DNA Sequencing System Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global DNA Sequencing System Sales Value by Region (2021-2032)
- 6.4.1 Global DNA Sequencing System Sales Value by Region: 2021-2026
- 6.4.2 Global DNA Sequencing System Sales Value by Region (2027-2032)
- 6.5 Global DNA Sequencing System Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America DNA Sequencing System Sales Value (2021-2032)
- 6.6.2 North America DNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe DNA Sequencing System Sales Value (2021-2032)
- 6.7.2 Europe DNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific DNA Sequencing System Sales Value (2021-2032)
- 6.8.2 Asia-Pacific DNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America DNA Sequencing System Sales Value (2021-2032)
- 6.9.2 South America DNA Sequencing System Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa DNA Sequencing System Sales Value (2021-2032)
- 6.10.2 Middle East & Africa DNA Sequencing System Sales Value Share by Country, 2025 VS 2032
7 DNA Sequencing System Country-level Sales and Value Analysis
- 7.1 Global DNA Sequencing System Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global DNA Sequencing System Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global DNA Sequencing System Sales by Country (2021-2032)
- 7.3.1 Global DNA Sequencing System Sales by Country (2021-2026)
- 7.3.2 Global DNA Sequencing System Sales by Country (2027-2032)
- 7.4 Global DNA Sequencing System Sales Value by Country (2021-2032)
- 7.4.1 Global DNA Sequencing System Sales Value by Country (2021-2026)
- 7.4.2 Global DNA Sequencing System Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.5.2 USA DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.9.2 France DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.16.2 China DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.19.2 India DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt DNA Sequencing System Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt DNA Sequencing System Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt DNA Sequencing System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BGI Genomics
- 8.1.1 BGI Genomics Company Information
- 8.1.2 BGI Genomics Business Overview
- 8.1.3 BGI Genomics DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.1.4 BGI Genomics DNA Sequencing System Product Portfolio
- 8.1.5 BGI Genomics Recent Developments
- 8.2 Biocompare
- 8.2.1 Biocompare Company Information
- 8.2.2 Biocompare Business Overview
- 8.2.3 Biocompare DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Biocompare DNA Sequencing System Product Portfolio
- 8.2.5 Biocompare Recent Developments
- 8.3 CEGAT
- 8.3.1 CEGAT Company Information
- 8.3.2 CEGAT Business Overview
- 8.3.3 CEGAT DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.3.4 CEGAT DNA Sequencing System Product Portfolio
- 8.3.5 CEGAT Recent Developments
- 8.4 Eurofins Group
- 8.4.1 Eurofins Group Company Information
- 8.4.2 Eurofins Group Business Overview
- 8.4.3 Eurofins Group DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Eurofins Group DNA Sequencing System Product Portfolio
- 8.4.5 Eurofins Group Recent Developments
- 8.5 Gencove
- 8.5.1 Gencove Company Information
- 8.5.2 Gencove Business Overview
- 8.5.3 Gencove DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Gencove DNA Sequencing System Product Portfolio
- 8.5.5 Gencove Recent Developments
- 8.6 Genewiz
- 8.6.1 Genewiz Company Information
- 8.6.2 Genewiz Business Overview
- 8.6.3 Genewiz DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Genewiz DNA Sequencing System Product Portfolio
- 8.6.5 Genewiz Recent Developments
- 8.7 Illumina
- 8.7.1 Illumina Company Information
- 8.7.2 Illumina Business Overview
- 8.7.3 Illumina DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Illumina DNA Sequencing System Product Portfolio
- 8.7.5 Illumina Recent Developments
- 8.8 Macrogen
- 8.8.1 Macrogen Company Information
- 8.8.2 Macrogen Business Overview
- 8.8.3 Macrogen DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Macrogen DNA Sequencing System Product Portfolio
- 8.8.5 Macrogen Recent Developments
- 8.9 New Scale Technologies
- 8.9.1 New Scale Technologies Company Information
- 8.9.2 New Scale Technologies Business Overview
- 8.9.3 New Scale Technologies DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.9.4 New Scale Technologies DNA Sequencing System Product Portfolio
- 8.9.5 New Scale Technologies Recent Developments
- 8.10 Oxford Nanopore Technologies
- 8.10.1 Oxford Nanopore Technologies Company Information
- 8.10.2 Oxford Nanopore Technologies Business Overview
- 8.10.3 Oxford Nanopore Technologies DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Oxford Nanopore Technologies DNA Sequencing System Product Portfolio
- 8.10.5 Oxford Nanopore Technologies Recent Developments
- 8.11 Pacific Biosciences of California
- 8.11.1 Pacific Biosciences of California Company Information
- 8.11.2 Pacific Biosciences of California Business Overview
- 8.11.3 Pacific Biosciences of California DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Pacific Biosciences of California DNA Sequencing System Product Portfolio
- 8.11.5 Pacific Biosciences of California Recent Developments
- 8.12 Qiagen
- 8.12.1 Qiagen Company Information
- 8.12.2 Qiagen Business Overview
- 8.12.3 Qiagen DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Qiagen DNA Sequencing System Product Portfolio
- 8.12.5 Qiagen Recent Developments
- 8.13 SCIEX
- 8.13.1 SCIEX Company Information
- 8.13.2 SCIEX Business Overview
- 8.13.3 SCIEX DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.13.4 SCIEX DNA Sequencing System Product Portfolio
- 8.13.5 SCIEX Recent Developments
- 8.14 Verogen
- 8.14.1 Verogen Company Information
- 8.14.2 Verogen Business Overview
- 8.14.3 Verogen DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Verogen DNA Sequencing System Product Portfolio
- 8.14.5 Verogen Recent Developments
- 8.15 MGI Tech
- 8.15.1 MGI Tech Company Information
- 8.15.2 MGI Tech Business Overview
- 8.15.3 MGI Tech DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.15.4 MGI Tech DNA Sequencing System Product Portfolio
- 8.15.5 MGI Tech Recent Developments
- 8.16 Thermo Fisher Scientific
- 8.16.1 Thermo Fisher Scientific Company Information
- 8.16.2 Thermo Fisher Scientific Business Overview
- 8.16.3 Thermo Fisher Scientific DNA Sequencing System Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Thermo Fisher Scientific DNA Sequencing System Product Portfolio
- 8.16.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 DNA Sequencing System Value Chain Analysis
- 9.1.1 DNA Sequencing System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 DNA Sequencing System Sales Mode & Process
- 9.2 DNA Sequencing System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 DNA Sequencing System Distributors
- 9.2.3 DNA Sequencing System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst